viscolin

from Viscum coloratum; structure in first source

Networked: 4 relevant articles (0 outcomes, 0 trials/studies)

1.	Inflammation (Inflammations) 06/01/2011 - "PPE-SVC and viscolin attenuate airway inflammation and eosinophil infiltration in OVA-sensitized mice." 11/01/2006 - "In summary, viscolin is a novel inhibitor of PDE and might be useful for treatment of neutrophilic inflammation." 06/01/2011 - "Partially purified extract and viscolin from Viscum coloratum attenuate airway inflammation and eosinophil infiltration in ovalbumin-sensitized mice."
2.	Atherosclerosis 10/01/2011 - "These results also suggest that viscolin may prevent the development of atherosclerosis and inflammatory responses."
3.	Respiratory Hypersensitivity 06/01/2011 - "The mice were randomized into groups and treated with PPE-SVC, viscolin, or rolipram by intraperitoneal injection on 1h before each inhalation of OVA and airway hyperresponsiveness (AHR). "
4.	Hyperplasia 01/01/2016 - "Furthermore, viscolin pre-treatment significantly reduced neointimal hyperplasia of an endothelial-denuded femoral artery in vivo. " 01/01/2016 - "Viscolin Inhibits In Vitro Smooth Muscle Cell Proliferation and Migration and Neointimal Hyperplasia In Vivo." 01/01/2016 - "Taken together, viscolin attenuated PDGF-BB-induced HASMC proliferation in vitro and reduced neointimal hyperplasia in vivo. "

1.	Intraperitoneal Injections